OCT 28 2014

Indonesia – Public and Private Participation in Universal Healthcare

Emerging Markets, Health Care, Universal Health Care

Under its National Health Strategic Plan (NHSP), Indonesia is continuously focusing on improving the quality and accessibility of its public healthcare system. NHSP (2010-2014) aims to enhance health status through involvement of private sector and civil society. It also focuses on the prevention and cure of health problems faced by the community through availability of…

Read the rest

APR 29 2014

Cambodia’s Social Health Insurance – In Need of Strong Government Support

Emerging Markets, Health Care, Universal Health Care

In the second part of our ongoing series on universal healthcare in the Southeast Asian countries, we review the social health insurance infrastructure, design and opportunities for healthcare industry stakeholders in Cambodia. Cambodia is a low income country (GNI per capita US$880 as of 2012) with a population of about 15 million (67th most populous…

Read the rest

APR 08 2014

Philippines’ Universal Healthcare – A Promising System Plagued by Inconsistent Quality of Service Delivery

Emerging Markets, Health Care, Universal Health Care

Over the years, governments across emerging markets have realised how critical universal healthcare coverage is for their population. While some countries have taken the challenge head-on, others have followed a wait-and-watch policy to see how such systems are being implemented, and gradually adopted a system that is based on the good practices of several healthcare…

Read the rest

NOV 07 2013

Global Pharmaceutical Market Scenario – Challenges, Action Plan and Potential Outcome

Emerging Markets, Health Care

Global pharmaceutical companies have suffered considerably on the face of patent expiry and lack of robust product pipeline in the last four-odd years. It is estimated that drug companies have on average seen a 20% decline in their revenues during 2009-2013 period. The ‘patent-cliff’ is around the corner and major drug companies can expect a…

Read the rest

DEC 13 2012

Essential Drugs in India – Is it all About Affordability?

Health Care

For a pharmaceutical company, establishing a balance between production cost, profitability and affordability of the drug for consumers is a delicate matter, with natural temptation to push the aspect of affordability to the back seat in search for profit maximization. Large pharmaceutical corporations have often been criticized for not undertaking sufficient efforts to promote availability…

Read the rest